MICHAEL VASCONCELLES - 16 Jun 2025 Form 3 Insider Report for Day One Biopharmaceuticals, Inc. (DAWN)

Signature
/s/ Charles N. York II, as Attorney-in-Fact
Issuer symbol
DAWN
Transactions as of
16 Jun 2025
Net transactions value
$0
Form type
3
Filing time
18 Jun 2025, 19:41:26 UTC
Previous filing
06 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
VASCONCELLES MICHAEL Head of Research and Dev. C/O DAY ONE BIOPHARMACEUTICALS, INC., 1800 SIERRA POINT PARKWAY, SUITE 200, BRISBANE /s/ Charles N. York II, as Attorney-in-Fact 18 Jun 2025 0001734755

No securities are beneficially owned.